title: Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.
abstract: OBJECTIVE
  To determine the behavioral, situational, and temporal effects of 4 months of methylphenidate (MPH) treatment for attention-deficit hyperactivity disorder (ADHD).
  
  
  METHODS
  Ninety-one children with ADHD were randomly assigned to receive either MPH (titrated to a target dose of 0.7 mg/kg twice a day) or a placebo. Treatment effects were investigated with measures sensitive to various behaviors (core and associated symptoms), situations (home and school), time periods (morning and afternoon, after reaching the target dose, and after 4 months of treatment), and side effects.
  
  
  RESULTS
  MPH treatment improved symptoms of ADHD and oppositional behavior at school, both in the morning and afternoon, but not at home. Side effects (increase in physiological and effective symptoms, lack of weight gain) were significantly more frequent with MPH than with placebo treatment. Benefit was evident after titration, but the onset of some side effects was delayed. Side effects were reported by parents but not by teachers.
  
  
  CONCLUSIONS
  Positive effects of MPH on behavior are evident in the classroom, but with MPH given twice daily, parents do not report that MPH improves behavior at home. Greater impact on home behavior may require three times daily MPH and combined treatments.
authors.affiliation: Department of Psychiatry, Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: R J
authors.initials: RJ
authors.lastname: Schachar
authors.forename: R
authors.initials: R
authors.lastname: Tannock
authors.forename: C
authors.initials: C
authors.lastname: Cunningham
authors.forename: P V
authors.initials: PV
authors.lastname: Corkum
mesh_terms: D000339:Affect / Q000187:drug effects; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002652:Child Behavior / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage* / Q000009:adverse effects; D013375:Substance Withdrawal Syndrome; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate